In a notification sent to PX on 11/05/2024, Lucky Core Industries Limited (LCI) has announced the acquisition of Pfizer’s manufacturing facility and pharmaceuticals in Karachi.
The Board of Directors of Lucky Core Industries Limited (the ‘Company’) have approved the purchase of a manufacturing facility owned by Pfizer Pakistan Limited located at B2 SITE Karachi, along with the acquisition of certain pharmaceutical products, and the acquisition of trademarks associated with the said pharmaceutical products (either through an outright assignment of the trademarks or a perpetual license to use the relevant trademarks) from relevant Pfizer group entities. The Board of Directors of the Company have further authorized the finalization and execution (as necessary) of the definitive transaction documents/agreements including the Asset Purchase Agreements, Trademark License Agreement and all ancillary documents forming part of the transaction with Pfizer Pakistan Limited and/or its group entities (as applicable). The completion of the transaction will be subject to receipt of necessary approvals and completion of formalities.
LCI shares were last trading at Rs. 795.91 today.
On 20-02-2025, Lotte Chemical Pakistan Limited (LOTCHEM) disclosed the following material information.
On the monthly time frame, Netsol has a history of boom and bust cycles
OIL & GAS EXPLORATION COMPANIES (OGDC) have made good corrections but it is still in…
The Board of Directors of Lotte Chemical Corporation, South Korea (LCC Korea), the majority (75.01%)…
After the completion of the expected life of the furnace, Ghani Global Glass Limited (GGGL)…
Pakistan State Oil (PSO) is trying to sustain above 300 level.